Recombinant Human MOCS2 Protein，His

MOCS2 (Molybdopterin Synthase 2) is a key enzyme involved in the biosynthesis of molybdenum cofactor in humans, which is essential for various biological processes, including the metabolism of sulfur-containing amino acids. Deficiencies in MOCS2 can lead to severe metabolic disorders, such as molybdenum cofactor deficiency, characterized by neurological impairments and sulfite toxicity. The study of recombinant MOCS2 proteins has gained significant attention as it provides insights into the enzyme's structure, function, and its role in enzymatic pathways. By expressing MOCS2 in heterologous systems, researchers can generate sufficient quantities of the enzyme for detailed biochemical characterization and to investigate its interactions with substrates and other associated proteins. This knowledge is crucial for understanding the molecular basis of MOCS2-related disorders and for developing potential therapeutic strategies. Furthermore, recombinant MOCS2 can be used in various applications, including enzyme engineering and biotechnological processes. Advances in recombinant DNA technology have made it feasible to produce MOCS2 in large scales, paving the way for in-depth studies concerning its mechanism of action and potential drug development for MOCS2-related diseases. Overall, research on recombinant MOCS2 not only enhances our understanding of fundamental biochemical processes but also holds promise for clinical applications in treating metabolic disorders associated with molybdenum cofactor deficiencies.